At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Secura ICDdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study to Evaluate System Safety and Clinical Performance of the SecuraTM ICD
In Brief
A clinical study evaluating Secura ICD for Tachyarrhythmias. Completed, enrolled 81 participants across 13 sites in 7 countries.
Detailed Summary
The purpose of the Secura clinical study is to evaluate the overall system safety and clinical performance of the Secura DR Implantable Cardioverter Defibrillator (ICD)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTachyarrhythmias
CountriesAustria, Finland, Germany, Greece, Netherlands, Saudi Arabia, Sweden
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2007
Enrollment StartOct 2007
Primary CompletionDec 2007
Study CompletionOct 2008
TodayJul 2026
First PostedSep 10, 2007
Enrollment StartOct 1, 2007
Primary CompletionDec 1, 2007
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 18.8 years ago
Interventions
Secura ICDdevice
Secura Implantable Cardioverter Defibrillator (ICD) will be implanted